Prime Medicine (PRME) Research & Development: 2021-2025
Historic Research & Development for Prime Medicine (PRME) over the last 4 years, with Sep 2025 value amounting to $44.0 million.
- Prime Medicine's Research & Development rose 9.05% to $44.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $160.0 million, marking a year-over-year decrease of 1.61%. This contributed to the annual value of $155.3 million for FY2024, which is 4.99% up from last year.
- According to the latest figures from Q3 2025, Prime Medicine's Research & Development is $44.0 million, which was up 6.32% from $41.4 million recorded in Q2 2025.
- Prime Medicine's 5-year Research & Development high stood at $52.9 million for Q4 2021, and its period low was $7.4 million during Q3 2021.
- Moreover, its 3-year median value for Research & Development was $40.6 million (2025), whereas its average is $39.0 million.
- Data for Prime Medicine's Research & Development shows a peak YoY increase of 238.47% (in 2022) and a maximum YoY decrease of 45.05% (in 2022) over the last 5 years.
- Prime Medicine's Research & Development (Quarterly) stood at $52.9 million in 2021, then tumbled by 45.05% to $29.1 million in 2022, then surged by 42.66% to $41.5 million in 2023, then declined by 17.74% to $34.1 million in 2024, then climbed by 9.05% to $44.0 million in 2025.
- Its Research & Development stands at $44.0 million for Q3 2025, versus $41.4 million for Q2 2025 and $40.6 million for Q1 2025.